Background: At Juntendo University Hospital, Japan, two patients with complete resection of bulky N2 non-small cell lung cancer (NSCLC) has survived over the long term. Therefore, we decided to retrospectively study patients who also had a complete resection of the tumor including the "bulky" superior mediastinal node for the purpose of reviewing covariates that might be related to the favorable outcome. Methods: We retrospectively analyzed the relation between covariates and survival after complete lobectomy and mediastinal lymph node resection (from April 1997 to August 2007) in 15 patients with bulky N2 NSCLC, lymph nodes greater than 2 cm in short-axis diameter (bulky nodal disease) measured on preoperative chest computer tomography. Results: Of 15 patients, 5 with bulky N2 single station had survival after the resection. Univariate analysis revealed that the postoperative stage significantly affected overall survival (p = 0.0101). Single-station node involvement in bulky N2 disease was the covariate associated with overall survival (p = 0.0150) and disease free survival (p = 0.0052). Conclusions: In the complete resection of bulky N2 NSCLC in patients with lymph nodes measuring more than 2 cm in short-axis diameter, single-station node involvement suggests a favorable outcome and long-term survival, compared to patients with multi-station involvement.
Introduction
Non-small cell lung carcinomas (NSCLC) featuring clinical mediastinal disease are often not amenable to complete resection. If complete surgical resection is done, the outcome is usually poor, especially for patients with bulky N2 disease. Therefore, these patients are usually treated with chemotherapy or chemoradiotherapy without resection. However, some patients with significant N2 disease have favorable outcomes. Roy et al. reported that patients with micrometastatic disease and single-station node involvement have the greatest chance for cure, and surgery has a significant role in their treatment. 1, 2) We experienced a case of a patient with long-term survival, in whom a complete resection of tumor with bulky mediastinal N2 dissection was performed. A characteristic of this case was swelling of a superior mediastinal node which was more than 2 cm in short-axis diameter, as measured by preoperative chest computed tomography (CT).
In order to identify subpopulations of patients with NSCLC who may have better prognoses, we retrospectively examined the outcomes of patients with superior mediastinal nodal metastasis, and determined whether the presence of bulky disease (>2 cm in short axis diameter) is predictive of long-term survival in patients undergoing complete resection.
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Patients and Methods
From April 1997 to August 2007, 15 patients with NSCLC featuring bulky N2 disease who had a complete resection including lobectomy and mediastinal lymph node dissection were included in the retrospective review. "Bulky" N2 disease was defined as involvement of mediastinal lymph nodes that were greater than 2 cm in shortaxis diameter, as measured by chest CT. Patients with multiple positive smaller lymph nodes and extranodal involvement were excluded from the review. Preoperative work-up included chest x-ray (CXR), CT scan of the chest and abdomen, magnetic resonance imaging (MRI) of the brain, and bone scintigram. The regional lymph node classification of Naruke was used. Postoperative work-up included CXR every three months, chest CT twice every year, and MRI of the brain, abdominal CT and bone scintigram once a year. Tumor markers were measured at least four times a year.
Statistical analysis of the data was carried out with Dr. SPSSII for Windows program (SPSS, Inc, Chicago, Illinois, USA). The survival curves and disease free survival curves were estimated by the method of Kaplan-Meier. Differences were evaluated with the log-rank test. Results with a P value of less than 0.05 were considered to be statistically significant.
Results
Median patient age was 55 years (range 34-70), and the male-to-female ratio was 12:3 ( Table 1 ). Preoperative T stage based on the chest CT was T1 in 7 patients (47%), T2 in 4 patients (27%), and T3 in 4 patients (27%). The histological type was adenocarcinoma in 10 patients (67%) and squamous cell carcinoma in 5 patients (33%). Primary location of lung carcinoma was right upper lobe in 11 patients (73%), left upper lobe in 3 patients (20%), and left lower lobe in 1 patient (7%). Postoperative lymph node metastasis was N2 in 9 patients (60%) and N3 in 6 patients (40%). Postoperative stage was IIIA in 8 patients (53%) and IIIB in 7 (47%) patients.
Lymph node dissection was ND3 in 10 patients (67%) and ND2 in 5 patients (33%). Adjuvant chemotherapy followed by operation was performed in 8 patients and operation alone in 7 patients ( Table 2) . Location of the bulky N2 node was #3 in 11 patients, #4 in 3 patients and #5 in one patient ( Table 3) . Bulky N2 single nodal station was present in 5 patients, and they all survived.
Disease-free survival rate was 33% (Fig. 1) . The overall survival rate was 47% (Fig. 2) . The 5-year disease-free survival rate for single-station node involvement was 80% versus 10% in 2 years for multi-station cases (Fig. 3) . The 5-year overall survival rate for single-station node involvement was 100% versus 18% in 4 years for multi-station cases (Fig. 4) . Of 5 patients with single-station node involvement, 2 patients had 114 and 117 months of diseasefree survival. Treatment for these patients was only the surgical resection without adjuvant chemotherapy. By univariate analysis, disease free survival (p = 0.0052, Table 4 ) and overall survival (p = 0.0150, Table  5 ) of the complete resection in patients with single station bulky N2 were statistically significant. The relation between overall survival and postoperative stage (p = 0.0101, Table 5 ) was statistically significantly.
Comments
Bulky N2 nodal disease is generally defined as involvement of lymph nodes with greater than 2 cm short-axis diameter as measured by chest CT, and generally implies extranodal involvement, multistation nodal disease, and/or groupings of multiple positive smaller lymph nodes.
3) It is thought that bulky N2, stage IIIA diseases cannot be resected, and these cases are traditionally treated with conventional radiotherapy alone.
In patients with NSCLC who have bulky N2 disease and a good performance status, ACCP evidence-based clinical practice guidelines recommend combination platinum-based chemotherapy and radiotherapy. 3) In patients with a good performance status and minimal weight loss, the guidelines recommend concurrent chemoradiotherapy over sequential chemoradiotherapy and do not recommend local treatment, including surgical resection, or radiation without chemotherapy.
Recently, induction chemotherapy or induction 
#, bulky lymph node; +, positive lymph node; -, negative lymph node chemoradiotherapy followed by surgery has been reported for patients with N2 disease added bulky N2 stage IIIA disease. 4) Yokomise and colleagues reported a series of patients who underwent induction chemoradiotherapy followed by surgery for bulky cN2 and cN3 NSCLC. 5) Thirty of 41 patients had bulky cN2 single-station disease. Histologic response rate was 78%, and 24 of 30 patients with cN2 disease underwent lobectomy or pneumonectomy. The overall 5-year survival rate was 48%. However, pneumonectomy was required in 13 cases. Pneumonectomy after induction chemotherapy has high morbidity and mortality. Kim and colleagues reported a series of patients with N2 disease treated with concurrent chemoradiotherapy and surgery.
6) The overall 5-year survival rate was 27% at most.
On the other hand, not all N2 disease necessarily portends an equally poor prognosis. Patients with micrometastatic disease and single-station nodal involvement have the greatest chance of being cured, and surgery has a significant role in their treatment.
1, 7-10) Riquest et al. report that involvement of only one mediastinal lymph node station is the main factor in offering a chance for a cure, with a 5-year overall survival of 29.6%, which is not the case when two or more chains are involved, which has a 12) However, patients with lymph nodes that are more than 2 cm in short-axis diameter, classified as bulky metastasis, have a poor prognosis. In our study, we noted long-term survival of patients with single-station bulky N2 lymph nodes metastasis, and in 4 of them, the primary lung carcinoma occupied the right upper lobe. Single-station node involvement in bulky N2 lymph node metastasis proved to be a favorable prognostic factor in patients with NSCLC who underwent lung resection with complete mediastinal lymph node dissection.
Regarding NSCLC lymphatic spread, the mediastinal lymph node chains drain the lymph into the blood circulation, either at the venous confluences of the neck or through the thoracic duct in the mediastinum, and simultaneously into neighboring ipsilateral and contralateral mediastinal lymph node chains by anastomotic lymphatics. 13, 14) When disease is located in only one lymph node chain, tumor cells with potentially metastatic properties may be absent or controlled within the lymph nodes. If this is the case, lymph node size by itself should not impact the prognosis. In fact, bulky N2 single-station metastasis may indicate a better prognosis.
In our study of 15 patients, we expected a poor prognosis for 6 with clinical stage IIIA disease (stage IIIB, according to postoperative staging) and a favorable outcome for 8 with clinical stage IIIA disease. Of these 8 patients, 5 had single station bulky N2 disease. By univariate analysis, postoperative stage and single station disease were significantly associated with overall survival. However, it is difficult to identify patients with single-station bulky N2 disease preoperatively. For surgery to be indicated, it is necessary to prove no metastasis to other mediastial lymph nodes except for the single-station bulky N2 lymph node metastasis. Although preoperative diagnostic capability has improved with refined imaging techniques, the preoperative diagnosis of lymph node metastasis is not accurate. Recently, PET-CT has become popular. Videtic et al. have reported that overall PET sensitivity was 61%, and positive predictive value was 94% in patients with NSCLC stage III. 15) PET generally tends to underestimate the extent of involved nodes. Until now, we have aggressively operated on patients with unclear mediastinal lymph node involvement apart from a bulky N2 lymph node, as determined from the results of chest CT.
The present study has several limitations. As the format is retrospective, this could have resulted in selection bias. Although all case had received more than standard lymph node dissection, extent of lymph node dissection is different for each case. In left lung cases, three cases had received extended lymph node dissection and one case had standard lymph node dissection. In patients with right lung disease, 7 had received extended lymph node dissection and 4, standard lymph node dissection. Also, the period of observation was relatively short; mean observation time was 35.2 months. We suggest that a favorable outcome may be had by a subgroup of patients with complete resection of singlestation N2 disease involving a node that has a greater than 2 cm short-axis diameter. The prognosis after resection in patients with single-station bulky N2 disease was better than in those with multi-station bulky N2 disease or N3 disease.
